Mark S. Freedman - Concepedia

Author

Mark S. Freedman

Also Known As

Elzbieta Jasinska, Freedman, M, Freedman, M., Freedman, Mark, J Barrera- Martinez, J-P Bouchard, M Freedman, M S FREEDMAN, M S Freedman, M. FREEDMAN

429

Publications

15.9K

Citations

H-Index

164

Concepts

All Affiliations

Ottawa Hospital University of Ottawa Ottawa Hospital Research Institute Montreal Neurological Institute and Hospital McGill University

About

Mark S. Freedman is an author at Ottawa Hospital specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	55	5.3K
2	Health Sciences	10	12	622
3	Public Health	9	9	410
4	Social Sciences	8	8	590
5	Engineering	3	3	60

Mark S. Freedman

140

Publications

12.4K

Citations

H-Index

Page 1

	Year	Citations
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial Kathleen Hawker, Paul O’Connor, Mark S. Freedman, Annals of Neurology	2009	924
A full genome search in multiple sclerosis George C. Ebers, Kim Kukay, Dennis E. Bulman, Nature Genetics MedicineGeneticsComplex DiseaseMultiple SclerosisFull Genome Search	1996	662
Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis Martin Duddy, Masaaki Niino, Femina Adatia, The Journal of Immunology	2007	637
Quantifying axonal loss after optic neuritis with optical coherence tomography Fiona Costello, Stuart G. Coupland, William Hodge, Annals of Neurology	2006	607
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Mark S. Freedman, Edward J. Thompson, Florian Deisenhammer, PubMed	2005	594
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes Ludwig Kappos, Chris H. Polman, Mark S. Freedman, American Journal of Ophthalmology Autoimmune DiseaseMcdonald MsImmunodeficienciesImmunologyMultiple Sclerosis	2006	551
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study Brenda Banwell, Lauren Krupp, Julia Kennedy, The Lancet Neurology Viral SerologiesViral PersistenceNeurological DisorderMedicineImmunology	2007	341
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial Ludwig Kappos, Hans‐Peter Hartung, Mark S. Freedman, The Lancet Neurology Neurological DisorderPain MedicineMedicineClinical NeurologyNeurological Progress	2014	325
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial Harold Atkins, Marjorie A. Bowman, David Allan, The Lancet Cell TherapyTransplantationMarrow TransplantationStem Cell MobilizationAggressive Multiple Sclerosis	2016	320
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis Paolo A. Muraro, Marcelo C. Pasquini, Harold Atkins, JAMA Neurology	2017	265

Page 1